Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease

被引:67
|
作者
Mun, Jeongeun [1 ]
Kim, Shintae [1 ]
Yoon, Ho-Geun [2 ]
You, Yanghee [1 ]
Kim, Ok-Kyung [1 ]
Choi, Kyung-Chul [3 ]
Lee, Yoo-Hyun [4 ]
Lee, Jeongmin [5 ]
Park, Jeongjin [1 ]
Jun, Woojin [1 ]
机构
[1] Chonnam Natl Univ, Div Food & Nutr, Gwangju 61186, South Korea
[2] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 03722, South Korea
[3] Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul 05505, South Korea
[4] Univ Suwon, Dept Food & Nutr, Gyeonggido 18323, South Korea
[5] Kyung Hee Univ, Dept Med Nutr, Gyeonggido 17104, South Korea
基金
新加坡国家研究基金会;
关键词
Curcuma longa L; non-alcoholic fatty liver disease; fatty acid uptake; lipid accumulation; oxidative stress; INDUCED OXIDATIVE STRESS; ANTIOXIDANT; DIET; EXPRESSION; PURIFICATION; GLUTATHIONE; RESISTANT; TRENDS; RATS;
D O I
10.3390/nu11102536
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Our aim was to investigate whether hot water extract (CLW) of Curcuma longa L. could prevent non-alcoholic fatty liver disease (NAFLD). HepG2 cells were treated with free fatty acid (FFA) mixture (oleic acid: palmitic acid, 2:1) for 24 h to stimulate in vitro fatty liver. In addition, C57BL/6 mice were fed 60 kcal% high-fat (HF) diet for eight weeks to induce fatty liver in vivo. Intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) productions were increased by FFA and HF-diet, but supplementation with CLW significantly decreased these levels. CLW treatment ameliorated antioxidant activities that were suppressed by exposure to the FFA and HF-diet. Cluster of differentiation 36 (CD36) and fatty acid transport proteins (FATP2 and FATP5) were increased in HF-diet groups, while CLW suppressed their expression levels. Moreover, sterol regulatory element-binding protein-1c (SREBP-1c), acetyl-coenzyme A carboxylase (ACC), and fatty acid synthase (FAS) expression levels were down-regulated in the CLW groups compared to HF-diet groups. On the other hand, 5 ' adenosine monophosphate-activated protein kinase (AMPK), Peroxisome proliferator-activated receptor alpha (PPAR-alpha), and carnitine palmitoyltransferase 1 (CPT-1) expressions were up-regulated in the CLW groups. HF-diet fed mice showed high hepatic triglycerides (TG) content compared to the normal diet mice. However, the administration of CLW restored the hepatic TG level, indicating an inhibitory effect against lipid accumulation by CLW. These results suggest that CLW could be a potentially useful agent for the prevention of NAFLD through modulating fatty acid uptake.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
    Miyake, Teruki
    Yoshida, Sakiko
    Furukawa, Shinya
    Sakai, Takenori
    Tada, Fujimasa
    Senba, Hidenori
    Yamamoto, Shin
    Koizumi, Yohei
    Yoshida, Osamu
    Hirooka, Masashi
    Kumagi, Teru
    Niiya, Tetsuju
    Miyaoka, Hiroaki
    Masanori, Abe
    Matsuura, Bunzo
    Hiasa, Yoichi
    OPEN MEDICINE, 2018, 13 (01): : 402 - 409
  • [2] Allopurinol Ameliorates Non-Alcoholic Fatty Liver Disease in Rats
    Korkmaz, Huseyin Anil
    Aktug, Huseyin
    Atila, Dincer
    Barisik, Vatan
    Arslan, Nur
    Erbas, Oytun
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 306 - 306
  • [3] Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat
    Saeedi, Golbahar
    Jeivad, Fereshteh
    Goharbari, Mohammadhadi
    Gheshlaghi, Gholamreza Hassanzadeh
    Sabzevari, Omid
    DRUG RESEARCH, 2018, 68 (10) : 553 - 559
  • [4] Vagal Stimulation Ameliorates Non-Alcoholic Fatty Liver Disease in Rats
    Elkattawy, Hany A.
    Mahmoud, Samar Mortada
    Hassan, Ahmed El-Sayed
    Behiry, Ahmed
    Ebrahim, Hasnaa Ali
    Ibrahim, Ateya Megahed
    Zaghamir, Donia Elsaid Fathi
    El-Sherbiny, Mohamed
    El-Sayed, Sherein F.
    BIOMEDICINES, 2023, 11 (12)
  • [5] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [6] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [7] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224
  • [8] Grape seed extract supplementation in non-alcoholic fatty liver disease
    Ghanbari, Parisa
    Alboebadi, Roghayeh
    Bazyar, Hadi
    Raiesi, Davoud
    Zarejavid, Ahmad
    Azadbakht, Mohammad Karim
    Karimi, Mahdi
    Razmi, Hamidreza
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2024, 94 (5-6) : 365 - 376
  • [9] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [10] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15